Josh Disbrow
Chairman and Chief Executive Officer
Replay available
Aytu BioPharma, Inc. (AYTU) Q1 2020 Earnings Call
Aytu BioPharma, Inc. (NASDAQ: AYTU) Q1 2020 earnings conference call, held 2029-11-14. Replay captured from the company's public earnings webcast.
Investor webinar replay
Meeting Overview The meeting was a business update call for A2 Bioscience, focusing on the company's operational and financial results for the first quarter of fiscal 2020. Key highlights included recent acquisitions, financial performance, and strategic plans for growth. Key Discussion Points - Overview of A2 Bioscience's transformation and growth during Q1 Fiscal 2020. - Planned acquisition of Anovus Pharmaceuticals and its expected impact on revenue and operations. - Closing of the CERACOR commercial portfolio acquisition. - Launch of three co-promotions for Heritage RX products. - Financial performance metrics, including increased product revenue and improved gross profit margins. - Integration plans for newly acquired companies and cost-saving measures. Decisions Made - No explicit decisions recorded. Action Items & Next Steps - [Unassigned] : File the joint S4 registration statement for review by the SEC by the end of the calendar year. - [Unassigned] : File a joint proxy stat...
Featured Presenters
Carl Burns
Analyst, Northland Capital Markets
Dave Green
Chief Financial Officer
Jeffrey Cohen
Analyst, Ladenburg Thalmann
Replay transcript excerpt
Speaker 1: Good afternoon, everyone, and thank you for joining us for the A2 Bioscience 1st 0.25 fiscal 2020 business update call. Speaker 1: With me this afternoon are A2's Chairman and Chief Executive Officer, Josh Gisbro, Speaker 1: and Chief Financial Officer, Dave Green. Speaker 1: A2 Bioscience issued a press release this afternoon with details of the company's operational and financial results. Speaker 1: A copy of the press release is available on the news page of the company's website at a2bio.com. Speaker 1: I'd like to remind everyone that today's call is being recorded. Speaker 1: A replay of today's call will be available by using the telephone numbers Speaker 1: and conference ID provided in the earnings press release. Speaker 1: In addition, a webcast will be accessible live and archived on A2Biosciences' Speaker 1: website within the investors section under Events and Presentations Speaker 1: at A2Bio.com. Speaker 1: Finally, I'd also like to call your attention to the customary Safe Harbor disclosure regarding forward-looking information. Speaker 1: The conference call today will contain certain forward-looking statements, including statements regarding the goals, Speaker 1: strategies, Speaker 1: beliefs, Speaker 1: expectations, Speaker 1: and future potential operating results of A2 Bioscience. Speaker 1: Although management believes these statements are reasonable based on estimates, assumptions, and projections as of today, November 14, Speaker 1: 2019, Speaker 1: These statements are not guarantees of future performance. Speaker 1: Time-sensitive information may no longer be accurate at the time of any telephonic or webcast replay. Speaker 1: Actual results may differ materially as a result of risks, uncertainties, and other factors, including ...